{"id":"W4253634880","doi":"10.1093/jnci/95.4.333","title":"RESPONSE: Re: A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma","year":2003,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Oncology; Placebo; Refractory (planetary science); Internal medicine; Randomized controlled trial; Prostate; Urology; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647988,0.002683711,0.005770554,0.0007707748,0.0007086871,0.001283582,0.001323562,0.003179237,0.01530878],"category_scores_gemma":[0.002435007,0.0009084538,0.002784214,0.000432522,0.001703637,0.001820431,0.000569613,0.004917459,0.002250572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008808249,"about_ca_system_score_gemma":0.0008669969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001316858,"about_ca_topic_score_gemma":0.00326863,"domain_scores_codex":[0.9990621,0.0004732582,0.00007394959,0.0001838327,0.00005620548,0.000150576],"domain_scores_gemma":[0.9990852,0.0002941444,0.000195752,0.0001016226,0.00006228743,0.0002609374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9892841,0.001177198,0.0001898453,0.0007190566,0.0007669136,0.0000267391,0.00002047047,0.0001679667,0.00121228,0.00006076323,0.0006269484,0.00574769],"study_design_scores_gemma":[0.9867144,0.01168111,0.0006446568,0.00001702062,0.0003102586,0.00001708186,0.00001088356,0.00007567478,0.0001435134,0.00006400424,0.0003123081,0.000009091706],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.9624199,0.01510794,0.001007309,0.004130932,0.002816868,0.004435191,0.0034283,0.0005302338,0.006123308],"genre_scores_gemma":[0.9798963,0.003436592,0.0008652899,0.003210132,0.001370774,0.002297189,0.001693878,0.00005535764,0.007174559],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.01530878,"threshold_uncertainty_score":0.05121291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02492830840962276,"score_gpt":0.3152262468569568,"score_spread":0.290297938447334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}